消化器および腸管治療薬の世界市場レポート 2025年

消化器および腸管治療薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で291億6,000万米ドルに成長します。予測期間の成長は、ヘルスケアへのアクセス、世界の健康イベント、健康意識の高まり、高齢化、革新的な製品開発に起因します。予測期間における主な動向は、ヘルスケアへのアクセス、環境要因、消費者教育、規制環境、医薬品の進歩などです。

胃腸障害の症例数の増加が、今後数年間の消化器および腸管治療薬市場の成長を促進すると予測されます。胃腸障害には、吐き気、嘔吐、食中毒、下痢など、胃腸（GI）管の生物学的機能全般に影響を及ぼすさまざまな疾患が含まれます。これらの疾患の有病率の増加により、消化管疾患を効果的に治療できる消化器および腸管治療薬に対する需要が高まっています。例えば、2024年1月、米国の非営利団体である米国がん協会は、2024年に米国で約26,890人の胃がん患者が新たに発生し、その内訳は男性が16,160人、女性が10,730人であると予測しました。さらに、このタイプのがんでは、男性6,490人、女性4,390人を含む約10,880人が死亡すると予想されています。その結果、胃腸障害の発生率の増加が消化器および腸管治療薬市場の成長を後押しすると予想されます。

遠隔医療サービスの拡大は、将来的に消化器および腸管治療薬市場の成長を高めると予想されます。遠隔医療サービスは、主にインターネットやビデオ会議ツールを活用し、通信技術を通じてヘルスケア、医療相談、臨床サービスを遠隔で提供するものです。遠隔医療サービスへのアクセシビリティが向上することで、消化器や腸の問題を抱える人々が、実際に訪問することなく、相談やアドバイスを受けるために便利にヘルスケアにアクセスできるようになるだけでなく、障害の早期介入や早期管理を促し、関連する治療薬や医薬品の需要を押し上げます。例えば、2022年10月、米国の政府機関である疾病対策予防センター（Centers for Disease Control and Prevention）の報告によると、成人の37.0%が過去12ヵ月間に遠隔医療サービスを利用したことがあるといいます。女性（42.0％）は男性（31.7％）に比べて遠隔医療を利用する傾向が顕著でした。さらに、年齢と遠隔医療の利用には正の相関関係があり、年齢が上がるにつれて遠隔医療を利用する成人の割合が増加しました。具体的には、利用率は18～29歳の成人の29.4％から65歳以上の43.3％に上昇しました。このように、遠隔医療サービスの成長が消化器および腸管治療薬市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の消化器および腸管治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の消化器および腸管治療薬市場：成長率分析
• 世界の消化器および腸管治療薬市場の実績：規模と成長, 2019-2024
• 世界の消化器および腸管治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の消化器および腸管治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の消化器および腸管治療薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消化器薬
• 胃腸の不調治療薬
• 天然および合成薬剤
• 世界の消化器および腸管治療薬市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児
• 大人
• 世界の消化器および腸管治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン
• オフライン
• 世界の消化器および腸管治療薬市場：消化器薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 制酸剤
• 消化酵素
• プロトンポンプ阻害剤（PPI）
• H2受容体拮抗薬
• 世界の消化器および腸管治療薬市場：胃腸障害のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 吐き気止め薬
• 下痢止め薬
• 下剤
• 胃保護剤
• 世界の消化器および腸管治療薬市場：天然物質と合成物質のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハーブ療法
• 合成鎮痙薬
• プロバイオティクスとプレバイオティクス

第7章 地域別・国別分析

• 世界の消化器および腸管治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の消化器および腸管治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 消化器および腸管治療薬市場：競合情勢
• 消化器および腸管治療薬市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Jiangzhong Pharmaceutical Co. Ltd.
• Johnson & Johnson Pvt. Ltd.
• Menarini Group
• Merck Co. & KGaA
• Pfizer Inc.
• Prestige Consumer Healthcare Inc.
• Procter & Gamble Company
• Reckitt Benckiser Group PLC
• Sanofi SA
• Takeda Pharmaceutical Company Limited
• AbbVie Inc.
• Alfa Wassermann and Sigma-Tau
• Allergan PLC
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 消化器および腸管治療薬市場2029：新たな機会を提供する国
• 消化器および腸管治療薬市場2029：新たな機会を提供するセグメント
• 消化器および腸管治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Digestive and intestinal remedies encompass medications designed to address gastrointestinal disorders, including issues like stomach upset, constipation, and diarrhea. The treatment process often involves the use of drug classes such as antacids, proton pump inhibitors, and histamine2 blockers.

The main types of digestive and intestinal remedies include digestive medicines, remedies targeting gastrointestinal complaints, and both natural and synthetic agents. Digestive medicines include compounds like digestive enzymes, which aid the body in breaking down and digesting meals. These medicines are particularly helpful in treating occasional heartburn, nausea, and upset stomach. They cater to various age groups, including pediatric and adult populations, and are distributed through various channels, such as online and offline platforms.

The digestive and intestinal remedies market research report is one of a series of new reports from The Business Research Company that provides digestive and intestinal remedies market statistics, including digestive and intestinal remedies industry global market size, regional shares, competitors with a digestive and intestinal remedies market share, detailed digestive and intestinal remedies market segments, market trends and opportunities, and any further data you may need to thrive in the digestive and intestinal remedies industry. This digestive and intestinal remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digestive and intestinal remedies market size has grown strongly in recent years. It will grow from $21.37 billion in 2024 to $22.5 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to traditional remedies, lifestyle changes, increased stress levels, dietary shifts, and COVID-19 impact.

The digestive and intestinal remedies market size is expected to see strong growth in the next few years. It will grow to $29.16 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to healthcare accessibility, global health events, rising health consciousness, ageing population, innovative product development. Major trends in the forecast period include healthcare access, environmental factors, consumer education, regulatory environment, pharmaceutical advancements.

The rising number of gastrointestinal disorder cases is anticipated to drive the growth of the digestive and intestinal remedy market in the coming years. Gastrointestinal disorders encompass a range of diseases, including nausea, vomiting, food poisoning, and diarrhea, which affect the overall biological functioning of the gastrointestinal (GI) tract. The increasing prevalence of these disorders has led to a heightened demand for digestive and intestinal remedies capable of effectively treating gastrointestinal diseases. For example, in January 2024, the American Cancer Society, a US-based non-profit organization, projected that around 26,890 new cases of stomach cancer would occur in the U.S. in 2024, with 16,160 cases in men and 10,730 in women. Additionally, this type of cancer is expected to result in approximately 10,880 deaths, including 6,490 men and 4,390 women. Consequently, the growing incidence of gastrointestinal disorders is expected to boost the growth of the digestive and intestinal remedy market.

The expansion of telemedicine services is expected to enhance the growth of the digestive and intestinal remedy market in the future. Telemedicine services involve the remote delivery of healthcare, medical consultations, and clinical services through telecommunications technology, primarily utilizing the Internet and video conferencing tools. The increased accessibility of telemedicine services not only allows individuals with digestive and intestinal issues to conveniently access healthcare for consultations and advice without the need for physical visits but also encourages early intervention and management of disorders, thereby boosting the demand for relevant remedies and medications. For example, in October 2022, a report from the Centers for Disease Control and Prevention, a US-based government agency, indicated that 37.0% of adults had used telemedicine services in the past 12 months. Women (42.0%) were notably more likely to utilize telemedicine compared to men (31.7%). Additionally, there was a positive correlation between age and telemedicine usage, with a rise in the percentage of adults engaging in telemedicine as they aged. Specifically, usage rates climbed from 29.4% among adults aged 18-29 to 43.3% among those aged 65 and older. Thus, the growth of telemedicine services is driving the expansion of the digestive and intestinal remedy market.

Technological advancements and developments are significant trends gaining traction in the digestive and intestinal remedy market. Major companies in this sector are concentrating on creating innovative technologies to manage and monitor digestive health. Recently, the market has seen the introduction of breath analyzers that collect clinical information related to the digestive system. For example, in February 2022, FoodMarble, an Ireland-based company that provides breath testing devices, launched the AIRE 2 digestive breath tester. This pocket-sized device enables individuals with digestive issues such as SIBO (Small Intestinal Bacterial Overgrowth) and IBS (Irritable Bowel Syndrome) to measure and monitor their digestion in real time, thereby helping them manage their health more effectively. This cutting-edge technology identifies foods that lead to rapid fermentation in the gut, which can trigger various digestive symptoms. Additionally, the device is designed for use by healthcare professionals to gain deeper insights into patients' digestive disorders, including IBS and SIBO.

Major companies in the digestive and intestinal remedy market are focusing on developing innovative products, including digital platforms, to reach larger customer bases, boost sales, and increase revenue. Digital platforms are online technology-based systems or frameworks that facilitate the creation, delivery, and interaction of digital content, services, or products. For example, in April 2023, Owlstone Medical, a UK-based biotechnology company, launched OMED Health to help patients understand their gut microbiome and effectively manage their digestive health. Initially focusing on digestive disorders, OMED Health aims to enhance the quality of life for individuals dealing with gut health issues by providing improved and expedited insights and control over their conditions. In the realm of digestive health, breath testing is emerging as an effective method for patients to monitor and manage symptoms. A unique feature of OMED Health's gut health tests is their capability to detect minute amounts of hydrogen and methane gases in breath, which allows for a convenient at-home collection process. These gases are critical indicators of gut health, signaling specific conditions and diseases.

In November 2022, Biocodex Group, a healthcare company based in France, successfully acquired Hilma for an undisclosed amount. This strategic acquisition is anticipated to enable Hilma to rapidly expand its omnichannel retail strategy, access new demographics, and foster innovation in product development. The decision to sell by Hilma was driven by the extensive global scale offered by Biocodex, a valuable asset in overcoming the challenges associated with growing a digitally-native brand in the current business landscape. These challenges include managing heightened marketing expenses, addressing logistical complexities, and recruiting specialists for wholesale account expansion. Hilma, the acquired company, is a US-based provider specializing in natural remedies. The acquisition reflects Biocodex's commitment to strengthening its position in the healthcare market and leveraging its global presence for the benefit of Hilma's growth and development.

Major companies operating in the digestive and intestinal remedies market are Bayer AG, Abbott Laboratories, Bausch Health Companies Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Jiangzhong Pharmaceutical Co. Ltd., Johnson & Johnson Pvt. Ltd., Menarini Group, Merck Co. & KGaA, Pfizer Inc., Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited, AbbVie Inc., Alfa Wassermann and Sigma-Tau, Allergan PLC, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Daiichi Sankyo Chemical Pharma Co. Ltd., Evoke Pharma Inc., Ipsen SA, Ironwood Pharmaceuticals Inc., Mundipharma, Mylan NV, Norgine Pharmaceuticals Ltd., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Perrigo Company, Recordati S.p.A., RedHill Biopharma Ltd., Ritter Pharmaceuticals Inc., Salix Pharmaceuticals Inc.

North America was the largest region in the digestive and intestinal remedies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digestive and intestinal remedies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digestive and intestinal remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digestive and intestinal remedies market consists of sales of antacids, prokinetic agents, laxatives, antidiarrheal agents, generic enzymes. Values in this market are ''''factory gate'''' values that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digestive and Intestinal Remedies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digestive and intestinal remedies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digestive and intestinal remedies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The digestive and intestinal remedies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Digestive Medicines; Remedies Against Gastrointestinal Complaints; Natural And Synthetic Agents
• 2) By Age Group: Pediatric; Adults
• 3) By Distribution Channel: Online; Offline
• Subsegments:
• 1) By Digestive Medicines: Antacids; Digestive Enzymes; Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists
• 2) By Remedies Against Gastrointestinal Complaints: Anti-Nausea Medications; Antidiarrheal Agents; Laxatives; Gastroprotective Agents
• 3) By Natural And Synthetic Agents: Herbal Remedies; Synthetic Antispasmodics; Probiotics And Prebiotics
• Companies Mentioned: Bayer AG; Abbott Laboratories; Bausch Health Companies Inc.; Eli Lilly and Company; GlaxoSmithKline PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digestive and Intestinal Remedies Market Characteristics

3. Digestive and Intestinal Remedies Market Trends And Strategies

4. Digestive and Intestinal Remedies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Digestive and Intestinal Remedies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Digestive and Intestinal Remedies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Digestive and Intestinal Remedies Market Growth Rate Analysis
• 5.4. Global Digestive and Intestinal Remedies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Digestive and Intestinal Remedies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Digestive and Intestinal Remedies Total Addressable Market (TAM)

6. Digestive and Intestinal Remedies Market Segmentation

• 6.1. Global Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digestive Medicines
• Remedies Against Gastrointestinal Complaints
• Natural And Synthetic Agents
• 6.2. Global Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric
• Adults
• 6.3. Global Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.4. Global Digestive and Intestinal Remedies Market, Sub-Segmentation Of Digestive Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antacids
• Digestive Enzymes
• Proton Pump Inhibitors (PPIs)
• H2-Receptor Antagonists
• 6.5. Global Digestive and Intestinal Remedies Market, Sub-Segmentation Of Remedies Against Gastrointestinal Complaints, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Nausea Medications
• Antidiarrheal Agents
• Laxatives
• Gastroprotective Agents
• 6.6. Global Digestive and Intestinal Remedies Market, Sub-Segmentation Of Natural And Synthetic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal Remedies
• Synthetic Antispasmodics
• Probiotics And Prebiotics

7. Digestive and Intestinal Remedies Market Regional And Country Analysis

• 7.1. Global Digestive and Intestinal Remedies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Digestive and Intestinal Remedies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digestive and Intestinal Remedies Market

• 8.1. Asia-Pacific Digestive and Intestinal Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digestive and Intestinal Remedies Market

• 9.1. China Digestive and Intestinal Remedies Market Overview
• 9.2. China Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digestive and Intestinal Remedies Market

• 10.1. India Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digestive and Intestinal Remedies Market

• 11.1. Japan Digestive and Intestinal Remedies Market Overview
• 11.2. Japan Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digestive and Intestinal Remedies Market

• 12.1. Australia Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digestive and Intestinal Remedies Market

• 13.1. Indonesia Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digestive and Intestinal Remedies Market

• 14.1. South Korea Digestive and Intestinal Remedies Market Overview
• 14.2. South Korea Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digestive and Intestinal Remedies Market

• 15.1. Western Europe Digestive and Intestinal Remedies Market Overview
• 15.2. Western Europe Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digestive and Intestinal Remedies Market

• 16.1. UK Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digestive and Intestinal Remedies Market

• 17.1. Germany Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digestive and Intestinal Remedies Market

• 18.1. France Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digestive and Intestinal Remedies Market

• 19.1. Italy Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digestive and Intestinal Remedies Market

• 20.1. Spain Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digestive and Intestinal Remedies Market

• 21.1. Eastern Europe Digestive and Intestinal Remedies Market Overview
• 21.2. Eastern Europe Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digestive and Intestinal Remedies Market

• 22.1. Russia Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digestive and Intestinal Remedies Market

• 23.1. North America Digestive and Intestinal Remedies Market Overview
• 23.2. North America Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digestive and Intestinal Remedies Market

• 24.1. USA Digestive and Intestinal Remedies Market Overview
• 24.2. USA Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digestive and Intestinal Remedies Market

• 25.1. Canada Digestive and Intestinal Remedies Market Overview
• 25.2. Canada Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digestive and Intestinal Remedies Market

• 26.1. South America Digestive and Intestinal Remedies Market Overview
• 26.2. South America Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digestive and Intestinal Remedies Market

• 27.1. Brazil Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digestive and Intestinal Remedies Market

• 28.1. Middle East Digestive and Intestinal Remedies Market Overview
• 28.2. Middle East Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digestive and Intestinal Remedies Market

• 29.1. Africa Digestive and Intestinal Remedies Market Overview
• 29.2. Africa Digestive and Intestinal Remedies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Digestive and Intestinal Remedies Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Digestive and Intestinal Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digestive and Intestinal Remedies Market Competitive Landscape And Company Profiles

• 30.1. Digestive and Intestinal Remedies Market Competitive Landscape
• 30.2. Digestive and Intestinal Remedies Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

31. Digestive and Intestinal Remedies Market Other Major And Innovative Companies

• 31.1. Jiangzhong Pharmaceutical Co. Ltd.
• 31.2. Johnson & Johnson Pvt. Ltd.
• 31.3. Menarini Group
• 31.4. Merck Co. & KGaA
• 31.5. Pfizer Inc.
• 31.6. Prestige Consumer Healthcare Inc.
• 31.7. Procter & Gamble Company
• 31.8. Reckitt Benckiser Group PLC
• 31.9. Sanofi SA
• 31.10. Takeda Pharmaceutical Company Limited
• 31.11. AbbVie Inc.
• 31.12. Alfa Wassermann and Sigma-Tau
• 31.13. Allergan PLC
• 31.14. AstraZeneca PLC
• 31.15. Boehringer Ingelheim International GmbH

32. Global Digestive and Intestinal Remedies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digestive and Intestinal Remedies Market

34. Recent Developments In The Digestive and Intestinal Remedies Market

35. Digestive and Intestinal Remedies Market High Potential Countries, Segments and Strategies

• 35.1 Digestive and Intestinal Remedies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Digestive and Intestinal Remedies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Digestive and Intestinal Remedies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer